VRAX
Virax Biolabs Group Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$1.40
−3.45%Leverage
- Debt / equity
- 0.05x
- Net debt / equity
- -0.80x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.05x
- Net debt / EBITDA
- 0.75x
Liquidity & coverage
- Current ratio
- 9.97x
- Quick ratio
- 9.90x
- Cash ratio
- 9.52x
- Interest coverage
- -96.86x
- EBITDA / interest
- -86.43x
- Working capital
- $6.1M
Cash & dividend
- FCF / debt
- -19.17x
- Cash flow / debt
- -18.21x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026